Ocuphire Pharma, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Ocuphire Pharma, Inc.
CIK #0001228627, 0001738266
EDGAR Form CIK 2011 - 2025
10-K [0001228627]
10-Q [0001228627]
3 [0001228627]
4 [0001228627]
5 [0001228627]
8-K [0001228627]
D [0001228627]
SC 13D [0001228627]
SC 13G [0001228627]
D [0001738266]
Form 13D/13G Filer Form 13D/13G Subject Filed
BIOS Fund III LP Opus Genetics Inc [2025-08-11]
Nantahala Capital Management LLC Opus Genetics Inc [2025-05-15]
Perceptive Advisors LLC Opus Genetics Inc [2025-03-31]
Foundation Fighting Blindness Retinal Degeneration Fund Opus Genetics Inc [2024-10-29]
Richmond Brothers Inc Ocuphire Pharma Inc [2022-05-17]
Apexian Pharmaceuticals Inc Ocuphire Pharma Inc [2021-03-26]
Sooch Mina Ocuphire Pharma Inc [2021-03-17]
Richmond Brothers Inc Ocuphire Pharma Inc [2020-11-16]
Altium Capital Management LP Ocuphire Pharma Inc [2020-11-16]
Empery Asset Management LP Ocuphire Pharma Inc [2020-11-12]
View All
Form 3/4/5 Subject 2011 - 2025
Opus Genetics, Inc.
Foundation Fighting Blindness, Inc.
Foundation Fighting Blindness Retinal Degeneration Fund
Graves Adrienne L
Bennett Jean
Ainsworth Sean
Rodgers Richard J
Manuso James S J
Gallagher Cam
Benton Susan
View All
Terms | Privacy | Guide
tony@aum13f.com